Clinical Trial 23103

An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects with Polycythemia Vera

Disease Site: Other

PI: Kuykendall, Andrew

Clinical Trial 22484

PRAGMATICA LUNG: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) plus Pembrolizumab (MK-3475; NSC 776864) versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer

Disease Site: Lung

PI: Saltos, Andreas

Clinical Trial 21681

Disease Site: Brain and Nervous System

PI: Vogelbaum, Michael

Clinical Trial 21399

Phase I Study of MEM-288 Oncolytic Virus in Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)

Disease Site: Lung

PI: Saltos, Andreas

Clinical Trial 21665

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine And Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

Disease Site: Other Digestive Organ, Pancreas

PI: Strosberg, Jonathan

Clinical Trial 20872

An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)

Disease Site: Other Female Genital

PI: Shahzad, Mian

Clinical Trial 19829

Disease Site: Lymphoid Leukemia, Non-Hodgkin's Lymphoma

PI: Shah, Bijal

Clinical Trial 19868

First in Human Phase I Study of 225Actinium-DOTA-Ahx-MC1RL (225Ac-MTI-201) in Metastatic Melanoma

Disease Site: Eye and Orbit, Melanoma, skin

PI: Khushalani, Nikhil

Clinical Trial 20110

GBM Agile: Global Adaptive Trial Master Protocol

Disease Site: Brain and Nervous System

PI: Grogan, Patrick

Clinical Trial 20068

A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Disease Site: Other Skin, Skin, Squamous Cell Carcinoma (SCC)

PI: Khushalani, Nikhil

Clinical Trial 21945

Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients with EGFR Inhibitor Induced Acneiform Lesions Protocol

Disease Site: Colon

PI: Imanirad, Iman

Clinical Trial 22086

A Phase II Study of CART-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Disease Site: Multiple Myeloma

PI: Freeman, Ciara